Cargando…

Changes in Choroidal Vascularity Index (CVI) in Intermediate Uveitis

PURPOSE: To investigate the longitudinal changes in choroidal vascularity index (CVI) in eyes with active and quiescent intermediate uveitis using enhanced depth imaging optical coherence tomography (EDI-OCT). METHODS: EDI-OCT images of eyes with active and quiescent intermediate uveitis were retros...

Descripción completa

Detalles Bibliográficos
Autores principales: Kongwattananon, Wijak, Kumar, Aman, Oyeniran, Enny, Sen, H. Nida, Kodati, Shilpa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727317/
https://www.ncbi.nlm.nih.gov/pubmed/34967835
http://dx.doi.org/10.1167/tvst.10.14.33
_version_ 1784626497876656128
author Kongwattananon, Wijak
Kumar, Aman
Oyeniran, Enny
Sen, H. Nida
Kodati, Shilpa
author_facet Kongwattananon, Wijak
Kumar, Aman
Oyeniran, Enny
Sen, H. Nida
Kodati, Shilpa
author_sort Kongwattananon, Wijak
collection PubMed
description PURPOSE: To investigate the longitudinal changes in choroidal vascularity index (CVI) in eyes with active and quiescent intermediate uveitis using enhanced depth imaging optical coherence tomography (EDI-OCT). METHODS: EDI-OCT images of eyes with active and quiescent intermediate uveitis were retrospectively reviewed and binarized using ImageJ software. Choroidal parameters including CVI, total choroidal area (TCA), luminal area (LA), stromal area (SA), and subfoveal choroidal thickness (SCT) were measured and compared between baseline and follow-up visits among eyes with active and quiescent intermediate uveitis. RESULTS: Thirty-eight eyes from 21 patients with active intermediate uveitis and 30 eyes from 17 patients with quiescent intermediate uveitis were included. CVI in eyes with active intermediate uveitis significantly increased from baseline (66.50% ± 3.40%) with resolution of inflammation on follow-up (68.82% ± 3.90%; P < 0.001). In eyes with quiescent intermediate uveitis at baseline eyes, CVI did not significantly change after follow-up (66.34% ± 3.19% to 66.25% ± 3.13%; P = 0.850). CONCLUSIONS: CVI significantly increased when active inflammation in intermediate uveitis resolved while CVI remained unchanged at follow-up in quiescent intermediate uveitis. TRANSLATIONAL RELEVANCE: CVI may be a useful noninvasive tool to monitor treatment response in intermediate uveitis. Our findings also highlight the involvement of choroidal vasculature in uveitic eyes without any clinical evidence of choroiditis.
format Online
Article
Text
id pubmed-8727317
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Association for Research in Vision and Ophthalmology
record_format MEDLINE/PubMed
spelling pubmed-87273172022-01-14 Changes in Choroidal Vascularity Index (CVI) in Intermediate Uveitis Kongwattananon, Wijak Kumar, Aman Oyeniran, Enny Sen, H. Nida Kodati, Shilpa Transl Vis Sci Technol Article PURPOSE: To investigate the longitudinal changes in choroidal vascularity index (CVI) in eyes with active and quiescent intermediate uveitis using enhanced depth imaging optical coherence tomography (EDI-OCT). METHODS: EDI-OCT images of eyes with active and quiescent intermediate uveitis were retrospectively reviewed and binarized using ImageJ software. Choroidal parameters including CVI, total choroidal area (TCA), luminal area (LA), stromal area (SA), and subfoveal choroidal thickness (SCT) were measured and compared between baseline and follow-up visits among eyes with active and quiescent intermediate uveitis. RESULTS: Thirty-eight eyes from 21 patients with active intermediate uveitis and 30 eyes from 17 patients with quiescent intermediate uveitis were included. CVI in eyes with active intermediate uveitis significantly increased from baseline (66.50% ± 3.40%) with resolution of inflammation on follow-up (68.82% ± 3.90%; P < 0.001). In eyes with quiescent intermediate uveitis at baseline eyes, CVI did not significantly change after follow-up (66.34% ± 3.19% to 66.25% ± 3.13%; P = 0.850). CONCLUSIONS: CVI significantly increased when active inflammation in intermediate uveitis resolved while CVI remained unchanged at follow-up in quiescent intermediate uveitis. TRANSLATIONAL RELEVANCE: CVI may be a useful noninvasive tool to monitor treatment response in intermediate uveitis. Our findings also highlight the involvement of choroidal vasculature in uveitic eyes without any clinical evidence of choroiditis. The Association for Research in Vision and Ophthalmology 2021-12-30 /pmc/articles/PMC8727317/ /pubmed/34967835 http://dx.doi.org/10.1167/tvst.10.14.33 Text en Copyright 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
spellingShingle Article
Kongwattananon, Wijak
Kumar, Aman
Oyeniran, Enny
Sen, H. Nida
Kodati, Shilpa
Changes in Choroidal Vascularity Index (CVI) in Intermediate Uveitis
title Changes in Choroidal Vascularity Index (CVI) in Intermediate Uveitis
title_full Changes in Choroidal Vascularity Index (CVI) in Intermediate Uveitis
title_fullStr Changes in Choroidal Vascularity Index (CVI) in Intermediate Uveitis
title_full_unstemmed Changes in Choroidal Vascularity Index (CVI) in Intermediate Uveitis
title_short Changes in Choroidal Vascularity Index (CVI) in Intermediate Uveitis
title_sort changes in choroidal vascularity index (cvi) in intermediate uveitis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727317/
https://www.ncbi.nlm.nih.gov/pubmed/34967835
http://dx.doi.org/10.1167/tvst.10.14.33
work_keys_str_mv AT kongwattananonwijak changesinchoroidalvascularityindexcviinintermediateuveitis
AT kumaraman changesinchoroidalvascularityindexcviinintermediateuveitis
AT oyeniranenny changesinchoroidalvascularityindexcviinintermediateuveitis
AT senhnida changesinchoroidalvascularityindexcviinintermediateuveitis
AT kodatishilpa changesinchoroidalvascularityindexcviinintermediateuveitis